520 related articles for article (PubMed ID: 20145032)
1. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN
Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032
[TBL] [Abstract][Full Text] [Related]
2. Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis.
Hong S; Pusapati RV; Powers JT; Johnson DG
Cell Cycle; 2006 Apr; 5(8):801-3. PubMed ID: 16582589
[TBL] [Abstract][Full Text] [Related]
3. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.
Maclean KH; Dorsey FC; Cleveland JL; Kastan MB
J Clin Invest; 2008 Jan; 118(1):79-88. PubMed ID: 18097482
[TBL] [Abstract][Full Text] [Related]
4. ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.
Pusapati RV; Rounbehler RJ; Hong S; Powers JT; Yan M; Kiguchi K; McArthur MJ; Wong PK; Johnson DG
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1446-51. PubMed ID: 16432227
[TBL] [Abstract][Full Text] [Related]
5. Role of the translocation partner in protection against AID-dependent chromosomal translocations.
Jankovic M; Robbiani DF; Dorsett Y; Eisenreich T; Xu Y; Tarakhovsky A; Nussenzweig A; Nussenzweig MC
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):187-92. PubMed ID: 19966290
[TBL] [Abstract][Full Text] [Related]
6. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
[TBL] [Abstract][Full Text] [Related]
7. The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.
Reimann M; Loddenkemper C; Rudolph C; Schildhauer I; Teichmann B; Stein H; Schlegelberger B; Dörken B; Schmitt CA
Blood; 2007 Oct; 110(8):2996-3004. PubMed ID: 17562874
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death.
Tian B; Yang Q; Mao Z
Nat Cell Biol; 2009 Feb; 11(2):211-8. PubMed ID: 19151707
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced apoptosis in developing mouse retina exhibits dose-dependent requirement for ATM phosphorylation of p53.
Borges HL; Chao C; Xu Y; Linden R; Wang JY
Cell Death Differ; 2004 May; 11(5):494-502. PubMed ID: 14752509
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
[TBL] [Abstract][Full Text] [Related]
11. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
Song H; Hollstein M; Xu Y
Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
[TBL] [Abstract][Full Text] [Related]
12. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
13. ATM is down-regulated by N-Myc-regulated microRNA-421.
Hu H; Du L; Nagabayashi G; Seeger RC; Gatti RA
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1506-11. PubMed ID: 20080624
[TBL] [Abstract][Full Text] [Related]
14. Regulation of activity and function of the p52 NF-κB subunit following DNA damage.
Barré B; Coqueret O; Perkins ND
Cell Cycle; 2010 Dec; 9(24):4795-804. PubMed ID: 21131783
[TBL] [Abstract][Full Text] [Related]
15. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
16. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
[TBL] [Abstract][Full Text] [Related]
17. Ataxia-telangiectasia mutated is not required for p53 induction and apoptosis in irradiated epithelial tissues.
Gurley KE; Kemp CJ
Mol Cancer Res; 2007 Dec; 5(12):1312-8. PubMed ID: 18171989
[TBL] [Abstract][Full Text] [Related]
18. FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage.
Chung YM; Park SH; Tsai WB; Wang SY; Ikeda MA; Berek JS; Chen DJ; Hu MC
Nat Commun; 2012; 3():1000. PubMed ID: 22893124
[TBL] [Abstract][Full Text] [Related]
19. A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity.
Kabacik S; Ortega-Molina A; Efeyan A; Finnon P; Bouffler S; Serrano M; Badie C
Cell Cycle; 2011 Apr; 10(7):1152-61. PubMed ID: 21389785
[TBL] [Abstract][Full Text] [Related]
20. ATM-dependent downregulation of USP7/HAUSP by PPM1G activates p53 response to DNA damage.
Khoronenkova SV; Dianova II; Ternette N; Kessler BM; Parsons JL; Dianov GL
Mol Cell; 2012 Mar; 45(6):801-13. PubMed ID: 22361354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
